Primary Children’s Hospital is a key contributor to a number of national and international groups striving to improve the lives of children, adolescents, young adults, and their families. Our caregivers play key roles within these groups to set the standards for pediatric cancer care.
When appropriate, we offer our patients the opportunity to participate in state of the art clinical trials, with the goal of increasing cure rates, identifying underlying causes of cancer, and decreasing late effects of cancer and cancer therapy.
Children’s Oncology Group
The Children’s Oncology Group (COG) is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 9,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across North America, Australia, New Zealand, and Europe in the fight against childhood cancer.
The Children’s Oncology Group has nearly 100 active clinical trials open at any given time. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship.
Therapeutic Advances in Childhood Leukemia (TACL)
The Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) consortium was formed in 2005 as a response to a need for a consortium that is focused on new drug studies in childhood leukemia and lymphoma. The TACL approach is to integrate translational laboratory research with early phase clinical trials to speed the progress of new therapy development for children with cancer.
Pediatric Oncology Experimental Therapeutic Investigators’ Consortium (POETIC)
he mission of the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC) is to promote the early clinical development of promising therapies for the treatment of children, adolescents, and young adults with cancer and related disorders
Pacific Pediatric Neuro-Oncology Consortium (PNOC)
The Pacific Pediatric Neuro-Oncology Consortium is a network of 18 children’s hospitals that conduct clinical trials of new therapies for children with brain tumors. The consortium’s goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.
Beat Childhood Cancer Research Consortium
The Beat Childhood Cancer research consortium is a group of 40+ universities and children's hospitals that offer a worldwide network of childhood cancer clinical trials. The consortium offers early phase clinical trials to children battling childhood cancer, with a focus on using precision medicine in patients at diagnosis as well as in difficult to treat relapsed and refractory cancers.
National Pediatric Cancer Foundation
The National Pediatric Cancer Foundation collaborates with over 20 children’s hospitals to bring together the nation’s top doctors and researchers to fast-track less toxic, more targeted treatment and increase the survival rate for children battling cancer. Capitalizing on the strengths of researchers from a variety of scientific fields, the Foundation has streamlined the process of protocol development in the hopes of delivering more personalized medicine to children with cancer